Log in

BIOWKS BIO-WORKS TECHNOLOGIES AB NGM · Sweden

BIO-WORKS TECHNOLOGIES AB (BIOWKS) news

BIO-WORKS TECHNOLOGIES AB is a public biotech or pharmaceutical company listed on NGM under the ticker BIOWKS, recorded under Sweden. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest BIO-WORKS TECHNOLOGIES AB news

We have not published a story on BIO-WORKS TECHNOLOGIES AB yet. When there is news, it will appear here.

Questions about BIO-WORKS TECHNOLOGIES AB

What is the ticker symbol of BIO-WORKS TECHNOLOGIES AB?

BIO-WORKS TECHNOLOGIES AB trades under the ticker BIOWKS on NGM.

Where is BIO-WORKS TECHNOLOGIES AB listed?

BIO-WORKS TECHNOLOGIES AB is listed on NGM.

Which country or territory is BIO-WORKS TECHNOLOGIES AB listed under?

Our directory records BIO-WORKS TECHNOLOGIES AB under Sweden.

What does BIO-WORKS TECHNOLOGIES AB do?

Our directory classifies BIO-WORKS TECHNOLOGIES AB as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of BIO-WORKS TECHNOLOGIES AB?

The ISIN recorded for BIO-WORKS TECHNOLOGIES AB is SE0007387089.

Does aibio.space cover BIO-WORKS TECHNOLOGIES AB?

aibio.space lists BIO-WORKS TECHNOLOGIES AB among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to BIO-WORKS TECHNOLOGIES AB?

Companies in our directory listed in the same country and business area as BIO-WORKS TECHNOLOGIES AB: Biovica International AB, Spago Nanomedical AB, Magle Chemoswed Holding AB, Mendus AB, SenzaGen AB, Intervacc AB.

Investor discussion: BIO-WORKS TECHNOLOGIES AB

Members talk about BIO-WORKS TECHNOLOGIES AB (BIOWKS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NGM:BIOWKS on TradingView.

Listing details

BIO-WORKS TECHNOLOGIES AB is a public biotech or pharmaceutical company listed on NGM under the ticker BIOWKS, recorded under Sweden. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
BIO-WORKS TECHNOLOGIES AB
Ticker
BIOWKS
Listing
NGM
Country or territory
Sweden
Business scope
Biotechnology
ISIN
SE0007387089
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.